Cited by 1,411Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Open access

Austin, M A, King, M C, Vranizan, K M, Krauss, R M·1990·Circulation

DOI 10.1161/01.cir.82.2.495

Open this paper in CoChat — free account Open PDF

Abstract

In a community-based study of 301 subjects from 61 nuclear families, two distinct phenotypes (denoted A and B) were identified by nondenaturing gradient gel electrophoretic analysis of low density lipoprotein (LDL) subclasses. Phenotype A was characterized by predominance of large, buoyant LDL particles, and phenotype B consisted of a major peak of small, dense LDL particles. Previous analysis of the family data by complex segregation analysis demonstrated that these phenotypes appear to be inherited as a single-gene trait. In the present study, the phenotypes were found to be closely associated with variations in plasma levels of other lipid, lipoprotein, and apolipoprotein measurements. Specifically, phenotype B was associated with increases in plasma levels of triglyceride and apolipoprotein B, with mass of very low and intermediate density lipoproteins, and with decreases in high density lipoprotein (HDL) cholesterol, HDL2 mass, and plasma levels of apolipoprotein A-I. Thus, the proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.82.2.495

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,111
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,895
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,885
Applied linear statistical models : regression, analysis of variance, and experimental designs
Neter, J., Wasserman, W., & Kutner, M. (1974) · Andalas University Repository (Andalas University) · Cited by 2,818
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415

Flagged first, then by citations

Show all 63 references

Research works printed but not linked: 13

Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364
Heiss G, Tyroler HA: Are apolipoproteins useful for evaluat- ing ischemic heart disease? A brief overview of the literature, in Lippel K (ed): Proceeding ofthe Workshop on Apolipoprotein Quantification. National Institutes of Health publication No. (NIH) 83-1266, 1983, pp 7-19
Krauss RM, Lindgren FT, Williams PT, Kelsy SF, Brensike J, Vranizan K, Detre KM, Levy RI: Intermediate density lipo- proteins and coronary artery disease progression in hypercho- lesterolemic men. Lancet 1987;2:62-66
Ernst N, Fisher M, Smith W, Gordon W, Rifkind BM, Little JA, Mishkel MA, Williams DO: The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption: The Lipid Research Clinics Program Prevalence Study. Circulation: 1980;62:41-52
Lindgren FT, Jensen LC, Hatch FT: The isolation and quan- titative analysis of serum lipoproteins, in Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181-274
Morton NE, Rao DC, Lalouel JM: Methods in genetic epi- demiology, in Klingberg MA (ed): Contributions to Epidemiol- ogy and Biostatistics. Basel, Karger, vol 4, 1983, pp 62-102
Snedecor GW, Cochran WG: Statistical Methods, ed 6. Ames, Iowa, Iowa State University Press, 1967
SAS Users Guide: Basics, Version 5 Edition.
SAS User Guide: Statistics, Version 5 Edition.
Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangeiwaia S: Triglyceride and Coronary Heart Disease Mortal- ity. The Lipid Research Clinics Follow-up Study presented at the American Heart Association 27th Conference on Cardio- vascular Disease Epidemiology, Chapel Hill, NC, 1987
Steiner G, Schwartz L, Shumak S, Poapst M: The association of increased levels of intermediate density lipoproteins with smoking and coronary heart disease. Circulation 1987; 75:124-130
Swinkels DW, Demacker PNM, Hendricks JCM, van t'Laar A: Low density lipoprotein subfractions and relationship to other risk factors in healthy individuals. Arteriosclerosis 1989; 9:604-613
Krauss RM, Albers JJ, Brunzell JD: An apolipoprotein B- enriched low density lipoprotein subspecies in familial com- bined hyperlipidemia. Clin Res 1983;31:503a

Sorted by citations

Items 401–500 of 1,000

Adiponectin Is Associated with Favorable Lipoprotein Profile, Independent of BMI and Insulin Resistance, in Adolescents
Magge, S. N., Stettler, N., Koren, D., Katz, L. E. L., Gallagher, P. R., Mohler, E. R., & Rader, D. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2364 · Cited by 53
Omega-3 Fatty Acids
Engler, M. M., & Engler, M. B. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200601000-00005 · Cited by 53
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
Sibley, S. D., Hokanson, J. E., Steffes, M. W., Purnell, J. Q., Marcovina, S. M., Cleary, P. A., & Brunzell, J. D. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1165 · Cited by 53
“In addition, elevated IDL (10), apoB (11), and triglyceride levels (12) and decreased HDL (13) levels have been associated with CVD and are frequently seen in concert with small dense LDL (14).”
Background
Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology
Kulkarni, K. R., Garber, D. W., Jones, M. K., & Segrest, J. P. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39710-8 · Cited by 53
Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern.
McKeigue, P., Laws, A., Chen, Y. I., Marmot, M. G., & Reaven, G. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1187 · Cited by 51
Lipids and Lipoproteins in Women
O’Brien, T., & Nguyen, T. T. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.3.235 · Cited by 53
Susceptibility of low-density lipoprotein to oxidative modification
Witztum, J. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90143-d · Cited by 53
“Manuscript submitted February 5, 1993, and accepted February 5, found as part of a phenotype that is associated with an increased risk for CAD [2].”
Background
Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients
Formiga, F., Meco, J. F., Pintó, X., Jacob, J., Moga, I., & Pujol, R. (2001) · Lupus · doi:10.1191/096120301669070811 · Cited by 52
Genetic Epidemiology of Low-Density Lipoprotein Subclass Phenotypes
Austin, M. A. (1992) · Annals of Medicine · doi:10.3109/07853899209166999 · Cited by 52
Self-citation
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
Bonilha, I., Hajduch, É., Luchiari, B., Nadruz, W., Goff, W. L., & Sposito, A. C. (2021) · Metabolites · doi:10.3390/metabo11120807 · Cited by 58
The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China
Yu, S., Yan, L., Yan, J., Sun, X., Fan, M., Liu, H., Li, Y., & Guo, M. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-022-01761-4 · Cited by 53
“Since sdLDL-C is predominant in phenotype B [38], AIP can be used as an indicator of the LDL phenotype and indirectly reflect sdLDL-C levels.”
Stearate-Enriched Plant Sterol Esters Lower Serum LDL Cholesterol Concentration in Normo- and Hypercholesterolemic Adults
Carr, T. P., Krogstrand, K. L. S., Schlegel, V. L., & Fernández, M. L. (2009) · Journal of Nutrition · doi:10.3945/jn.109.106328 · Cited by 51
Lifestyle Changes: Effect of Diet, Exercise, Functional Food, and Obesity Treatment on Lipids and Lipoproteins
Enkhmaa, B., Surampudi, P. N., Anuurad, E., & Berglund, L. (2015) · Europe PMC (PubMed Central) · Cited by 50
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects
Davidson, M. H., Bays, H. E., Stein, E., Maki, K. C., Shalwitz, R. A., & Doyle, R. (2006) · Clinical Cardiology · doi:10.1002/clc.4960290609 · Cited by 51
The epidemiology of triglyceride as a coronary artery disease risk factor
Miller, M. J. (1999) · Clinical Cardiology · doi:10.1002/clc.4960221402 · Cited by 51
Current Awareness
Roth, J. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200007/08)16:4
High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia
Hirano, T., Oi, K., Sakai, S., Kashiwazaki, K., Adachi, M., & Yoshino, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00150-6 · Cited by 51
Insulin Resistance, Impaired Postprandial Lipid Metabolism and Abdominal Obesity
Frayn, K. N. (2002) · Medical Principles and Practice · doi:10.1159/000066414 · Cited by 49
Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels
Hayashi, T., Koba, S., Ito, Y., & Hirano, T. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0417-6 · Cited by 50
“5 nm were determined of having the small-sized LDL phenotype, pattern B [22].”
Influential
Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes
Vakkilainen, J., Mero, N., Schweizer, A., Foley, J. E., & Taskinen, M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.324 · Cited by 53
“However, because of the close correlations between small, dense LDL, hypertriglyceridemia, and low HDL cholesterol [10], it is difficult to dissect out whether small LDL particles are an independent risk factor or are merely a marker of other factors with causal relationship to”
Background
The Role of Dietary Fat in Child Nutrition and Development: Summary of an ASNS Workshop
Milner, J. A., & Allison, R. G. (1999) · Journal of Nutrition · doi:10.1093/jn/129.11.2094 · Cited by 52
Hypertriglyceridemia and risk of coronary heart disease
Hokanson, J. E. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0112-7 · Cited by 50
Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides*
Cabezas, M. C., Erkelens, D. W., Kock, L. A., & de Bruin, T. W. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01059.x · Cited by 50
Fluvastatin Lowers Atherogenic Dense Low-Density Lipoproteins in Postmenopausal Women With the Atherogenic Lipoprotein Phenotype
März, W., Scharnagl, H., Abletshauser, C., Hoffmann, M. M., Berg, A., Keul, J., Wieland, H., & Baumstark, M. W. (2001) · Circulation · doi:10.1161/01.cir.103.15.1942 · Cited by 50
Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia
Superko, H. R., Greenland, P., Manchester, R. A., Andreadis, N. A., Schectman, G., West, N. H., Hunninghake, D. B., Haskell, W. L., & Probstfield, J. L. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91264-5 · Cited by 50
Postprandial Lipoprotein Metabolism
Sethi, S. K., Gibney, M. J., & Williams, C. M. (1993) · Nutrition Research Reviews · doi:10.1079/nrr19930011 · Cited by 50
Segregation Analysis of Plasma Apolipoprotein B Levels in Familial Combined Hyperlipidemia
Bredie, S. J. H., van Drongelen, J., Kiemeney, L. A. L. M., Demacker, P. N. M., Beaty, T. H., & Stalenhoef, A. F. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.5.834 · Cited by 50
Cardiovascular and Hormonal Aspects of Very‐Low‐Carbohydrate Ketogenic Diets
Volek, J. S., & Sharman, M. J. (2004) · Obesity Research · doi:10.1038/oby.2004.276 · Cited by 50
Hypertriglyceridaemia and vascular risk
Tan, K. C. B., Betteridge, D. J., Marmot, M. G., Talmud, P. J., Humphries, S. E., & Yudkin, J. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91544-v · Cited by 52
Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil
Tilly-Kiesi, M., & Tikkanen, M. J. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00370.x · Cited by 49
Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70
Ohira, M., Endo, K., Oyama, T., Yamaguchi, T., Ban, N., Kawana, H., Nagayama, D., Nagumo, A., Saiki, A., Murano, T., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.001 · Cited by 47
Racial differences in coronary artery calcification are not attributed to differences in lipoprotein particle sizes: The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study
Aiyer, A., Kip, K. E., Marroquin, O. C., Mulukutla, S. R., Edmundowicz, D., & Reís, S. E. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.11.002 · Cited by 48
Small, dense low-density lipoprotein as a risk factor for coronary heart disease
Austin, M. A. (1994) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592460 · Cited by 48
Self-citation
Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040108 · Cited by 50
New Insights into Lipid Metabolism in Non-insulin-dependent Diabetes Mellitus
Taskinen, M., Lahdenperä, S., & Syvänne, M. (1996) · Annals of Medicine · doi:10.3109/07853899608999090 · Cited by 48
Lipoprotein correlates of LDL particle size
Rainwater, D. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00216-6 · Cited by 48
“atherogenic lipoprotein phenotype [1], which also includes low levels of high-density lipoprotein cholesterol”
Background
The biology of the artery wall in atherogenesis
O’Brien, K. D., & Chait, A. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30176-6 · Cited by 48
Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy
Yuan, J., Tsaic, M. Y., & Hunninghake, D. B. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90062-0 · Cited by 48
Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
Paublini, H., López‐González, Á. A., Busquets-Cortés, C., Tomás-Gil, P., Sbert, P. R., & Ramírez‐Manent, J. I. (2023) · Nutrients · doi:10.3390/nu15092105 · Cited by 50
“Atherogenic dyslipidaemia (AD) [1] and lipid triad (LT) [2,3] are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol [4,5].”
Background
Significance of Small Dense Low-Density Lipoprotein as a Risk Factor for Coronary Artery Disease and Acute Coronary Syndrome
Kwon, S. W., Yoon, S., Kang, T. S., Kwon, H. M., Kim, J., Rhee, J., Lee, S.-J., Park, J., Lim, J. Y., Yoon, Y. W., et al. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.3.405 · Cited by 47
Vitamin E/Lipid Peroxide Ratio and Susceptibility of LDL to Oxidative Modification in Non–Insulin-Dependent Diabetes Mellitus
Yoshida, H., Ishikawa, T., & Nakamura, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1438 · Cited by 47
Formation ofN‐acyl‐phosphatidylethanolamine andN‐acylethanolamine (including anandamide) during glutamate‐induced neurotoxicity
Hansen, H. S., Moesgaard, B., Hansen, H. H., Schousboe, A., & Petersen, G. (1999) · Lipids · doi:10.1007/bf02562333 · Cited by 47
Clinical significance of lipoprotein size and risk for coronary atherosclerosis
Roheim, P. S., & Asztalos, B. F. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.147 · Cited by 47
A moderate-fat diet containing pistachios improves emerging markers of cardiometabolic syndrome in healthy adults with elevated LDL levels
Holligan, S. D., West, S. G., Gebauer, S. K., Kay, C. D., & Kris‐Etherton, P. M. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001561 · Cited by 46
Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients
Lemieux, I., Houde, I., Pascot, A., Lachance, J.-G., Noël, R., Radeau, T., Després, J., & Bergeron, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00611.x · Cited by 46
Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: A meta-analysis of prospective cohort studies
Wang, Y., Lammi‐Keefe, C. J., Hou, L., & Hu, G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.009 · Cited by 46
“[46] Austin MA, King MC, Vranizan KM, Krauss RM.”
Background
Metabolic Syndrome: Maladaptation to a Modern World
Wilkin, T. J., & Voss, L. D. (2004) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.97.11.511 · Cited by 46
Lovastatin and Extended-Release Niacin Combination Product: The First Drug Combination for the Management of Hyperlipidemia
Gupta, E. K., & Ito, M. K. (2002) · Heart Disease · doi:10.1097/00132580-200203000-00010 · Cited by 46
Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
Schamberger, B., Geiss, H. C., Ritter, M. M., SCHWANDT, P., & Parhofer, K. G. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32381-6 · Cited by 46
VASCULAR DISEASE AND LIPIDS IN DIABETES
Garber, A. J. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70030-4 · Cited by 46
Diabetic dyslipidaemia
Betteridge (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00002.x · Cited by 45
LDL Size Distribution in Relation to Insulin Sensitivity and Lipoprotein Pattern in Young and Healthy Subjects
Ambrosch, A., Mühlen, I., Kopf, D., Augustus, W., Dierkes, J., König, W., Luley, C. H., & Lehnert, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2077 · Cited by 46
“Epidemiological studies suggested that a predominance of LDL pattern B is highly atherogenic and may become a nontraditional risk factor of coronary artery disease (2-4).”
Background
Evidence for an Exaggerated Postprandial Lipemia in Chronic Paraplegia
Nash, M. S., deGroot, J., Martinez‐Arizala, A., & Mendez, A. J. (2005) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2005.11753827 · Cited by 45
Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia
Llurba, E., Casals, E., Domı́nguez, C., Delgado, J., Mercadé, I., Crispi, F., Martı́n-Gallán, P., Cabero, L., & Gratacós, E. (2005) · Metabolism · doi:10.1016/j.metabol.2005.05.017 · Cited by 45
“Hypertriglyceridemia strongly correlates with a predominance of these subfractions in patients with atherosclerosis [15,16].”
Background
Small dense LDL particles - a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study
Toft‐Petersen, A. P., Tilsted, H. H., Aarøe, J., Rasmussen, K., Christensen, T., Griffin, B. A., Aardestrup, I. V., Andreasen, A., & Schmidt, E. B. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-21 · Cited by 45
“Recognition of an intimate metabolic relationship between triglycerides and other lipids has fuelled debate as to which component is the principal marker of CVD risk and has given rise to the description of a lipid phenotype consisting of a high proportion of small dense LDL, high levels of triglycerides, and low conc…”
Background
High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy
Hirano, T., Naito, H., Kurokawa, M., Ebara, T., Nagano, S., Adachi, M., & Yoshino, G. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05772-2 · Cited by 45
Different effects of diets rich in olive oil, rapeseed oil and sunflower-seed oil on postprandial lipid and lipoprotein concentrations and on lipoprotein oxidation susceptibility
Nielsen, N. S., Pedersen, A. T., Sandström, B., Marckmann, P., & Høy, C. (2002) · British Journal Of Nutrition · doi:10.1079/bjnbjn2002567 · Cited by 45
Subclasses of Low-Density Lipoprotein and Very Low-Density Lipoprotein in Familial Combined Hyperlipidemia: Relationship to Multiple Lipoprotein Phenotype
Georgieva, A. M., van Greevenbroek, M. M. J., Krauss, R. M., Brouwers, M. C. G. J., Vermeulen, V. M. M.-J., Robertus-Teunissen, M. G., Kallen, C., & de Bruin, T. W. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000119681.47218.a4 · Cited by 45
Self-citation
In vitro production of β-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase
Chung, B. H., Segrest, J. P., & Franklin, F. A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00169-5 · Cited by 45
Novel Cardiac-Specific Biomarkers and the Cardiovascular Continuum
Vassiliadis, E., Barascuk, N., Didangelos, A., & Karsdal, M. A. (2012) · Biomarker Insights · doi:10.4137/bmi.s9536 · Cited by 42
Serum uric acid: Marker for atherosclerosis as it is positively associated with “atherogenic index of plasma”
Baliarsingh, S., Sharma, N., & Mukherjee, R. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.732580 · Cited by 44
“Increased sdLDL has strong associations with increased TG and decreased HDL-C levels which is described as the “atherogenic lipoprotein phenotype” (Austin et al., 1999; Rizzo & Bernies, 2005).”
Background
Exercise and Coronary Heart Disease
Akyüz, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_11 · Cited by 47
Cardiovascular disease: Pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke
Castelli, W. P. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70695-2 · Cited by 44
Component Analysis of HPLC Profiles of Unique Lipoprotein Subclass Cholesterols for Detection of Coronary Artery Disease
Okazaki, M., Usui, S., Fukui, A., Kubota, I., & Tomoike, H. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070094 · Cited by 44
“The atherogenic lipoprotein phenotype has been defined as the presence of a predominance of small, dense LDL particles and high TG and low HDL-C concentrations (6, 7).”
Background
A rapid single-step centrifugation method for determination of HDL, LDL, and VLDL cholesterol, and TG, and identification of predominant LDL subclass
Sawle, A., Higgins, M. K., Olivant, M. P., & Higgins, J. A. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30176-0 · Cited by 44
Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention
McNair, E. D., Wells, C. R., Qureshi, A. M., Basran, R., Pearce, C., Orvold, J., Devilliers, J., & Prasad, K. (2010) · Clinical Cardiology · doi:10.1002/clc.20815 · Cited by 44
The small, dense LDL phenotype as a correlate of postprandial lipemia in men
Lemieux, I., Couillard, C., Pascot, A., Bergeron, N., Prud’homme, D., Bergeron, J., Tremblay, A., Bouchard, C., Mauriège, P., & Després, J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00424-x · Cited by 44
“cholesterol levels) profile which accompany the small, dense LDL phenotype [5–8].”
Background
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients
Chin, C. C., Rosenthal, D. N., & Bernstein, D. (2000) · Pediatric Transplantation · doi:10.1034/j.1399-3046.2000.00112.x · Cited by 44
Linkage of Low-Density Lipoprotein Size to the Lipoprotein Lipase Gene in Heterozygous Lipoprotein Lipase Deficiency
Hokanson, J. E., Brunzell, J. D., Jarvik, G. P., Wijsman, E. M., & Austin, M. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302234 · Cited by 45
“LDL subclass phenotypes were defined as described elsewhere (Austin et al. 1988a; Austin et al. 1990b).”
BackgroundMethodInfluentialSelf-citation
Dietary carbohydrates and triacylglycerol metabolism
Roche, H. M. (1999) · Proceedings of The Nutrition Society · doi:10.1079/pns19990026 · Cited by 44
Plasma triglyceride and low density lipoprotein metabolism
CASLAKE, M. J., Packard, C. J., Series, J. J., Yip, B., Dagen, M., & SHEPHERD, J. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01942.x · Cited by 44
Atherosclerosis — do we know enough already to prevent it?
Narasimhulu, C. A., Fernández-Ruíz, I., Selvarajan, K., Jiang, X., Sengupta, B., Riad, A., & Parthasarathy, S. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.02.006 · Cited by 45
“LDL consists of a heterogeneous group of particles with highly variable atherogenic potential [27].”
Background
Effects of Monounsaturated Enriched Sunflower Oil on CHD Risk Factors Including LDL Size and Copper-Induced LDL Oxidation
Ashton, E., Best, J. D., & Ball, M. J. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719052 · Cited by 43
Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia
Brites, F. D., Verona, J., Schreier, L. E., Fruchart, J., Castro, G. R., & Wikinski, R. L. W. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.02.002 · Cited by 43
LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes
Lahdenperä, S., Sane, T., Vuorinen-Markkola, H., Knudsen, P., & Taskinen, M. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05450-w · Cited by 43
Association Between Serum Fibrinogen Concentrations and HDL and LDL Subfraction Phenotypes in Healthy Men
Halle, M., Berg, A., Keul, J., & Baumstark, M. W. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.144 · Cited by 43
Low‐density‐lipoprotein peak particle size in a Mediterranean population
Rizzo, M., Barbagallo, C. M., Severino, M., Polizzi, F., Onorato, F., Noto, D., Cefalu, A. B., Pace, A., Marino, G., Notarbartolo, A., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01125.x · Cited by 43
Plasma Triglyceride and Coronary Heart Disease
Austin, M. A. (1992) · Medical science symposia series · doi:10.1007/978-94-011-2700-4_30 · Cited by 43
Self-citation
Premenopausal Advantages in Postprandial Lipid Metabolism Are Lost in Women With Type 2 Diabetes
Masding, M. G., Stears, A. J., Burdge, G. C., Wootton, S. A., & Sandeman, D. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3243 · Cited by 42
“The resultant lipoprotein profile of small dense LDL, low HDL cholesterol levels, and hypertriglyceridemia is typical of type 2 diabetes and is recognized to be particularly atherogenic (26).”
Background
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes
Chatterjee, S., Majumder, A., & Ray, S. (2015) · Scientific Reports · doi:10.1038/srep07706 · Cited by 42
Hypothyroidism Results in Small Dense LDL Independent of IRS Traits and Hypertriglyceridemia
Abbas, J. M. K., Chakraborty, J., Akanji, A. O., & Doi, S. A. R. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-065 · Cited by 42
Polyacrylamide Gradient Gel Electrophoresis of Lipoprotein Subclasses
Warnick, G. R., McNamara, J. R., Boggess, C. N., Clendenen, F., Williams, P. T., & Landolt, C. C. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.005 · Cited by 42
Reversal of Small, Dense LDL Subclass Phenotype by Normalization of Adiposity
Siri‐Tarino, P. W., Williams, P. T., Fernstrom, H. A., Rawlings, R. S., & Krauss, R. M. (2009) · Obesity · doi:10.1038/oby.2009.146 · Cited by 42
“Overweight and obesity have been associated with an atherogenic lipoprotein phenotype (ALP) that is characterized by elevated triacylglycerols (TGs), reduced high-density lipoprotein (HDL) cholesterol and increased concentrations of small, dense low-density lipoprotein (LDL subclass pattern B) (1,2).”
BackgroundSelf-citation
Plasma Lipoproteins and Triacylglycerol are Predictors of Small, Dense LDL Particles
Tsimihodimos, V., Gazi, I. F., Kostara, C. E., Tselepis, A. D., & Elisaf, M. (2007) · Lipids · doi:10.1007/s11745-007-3050-8 · Cited by 42
Autoantibodies to oxidized LDL and cardiovascular risk: The Framingham Offspring Study
Wilson, P. W. F., Ben‐Yehuda, O., McNamara, J., Massaro, J. M., Witztum, J. L., & Reaven, P. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.013 · Cited by 42
“Observational studies and clinical trials have repeatedly hown that the plasma concentration of low density lipoproein (LDL) cholesterol is a key factor in the development f clinical arteriosclerosis [1,2] Interest in risk factors for therosclerosis and cardiovascular disease events has now rogressed to assessing aspe…”
Background
Influence of mild to moderately elevated triglyceride’s on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels
Halle, M., Berg, A., Baumstark, M. W., König, D., Huonker, M., & Keul, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00278-0 · Cited by 43
“These particles have shown to be prevalent in patients with CAD [18–24].”
Background
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations.
Bossé, Y., Pérusse, L., & Vohl, M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400002-jlr200 · Cited by 41
“LDL size: a component of the metabolic syndrome and a trait representing a common atherogenic lipoprotein profile The metabolic syndrome is characterized by a cluster of CAD risk factors, including hypertension, upper body obesity, glucose intolerance, and the atherogenic lipoprotein phenotype, which consists of incre…”
BackgroundInfluential
Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles.
Katzel, L. I., Krauss, R. M., & Goldberg, A. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1121 · Cited by 41
Self-citation
LDL subclasses in IDDM patients: relation to diabetic nephropathy
Lahdenper, S., Groop, P., Tilly-Kiesi, M., Kuusi, T., Elliott, T. G., Viberti, G. C., & Taskinen, M. (1994) · Diabetologia · doi:10.1007/bf00417692 · Cited by 42
The effect of n−3 fatty acids on low density lipoprotein subfractions
Griffin, B. A. (2001) · Lipids · doi:10.1007/s11745-001-0688-6 · Cited by 42
Differences in the concentration and composition of low-density lipoprotein subfraction particles between sedentary and trained hypercholesterolemic men
Halle, M., Berg, A., König, D., Keul, J., & Baumstark, M. W. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90300-0 · Cited by 41
Lipoproteínas de alta densidade: aspectos metabólicos, clínicos, epidemiológicos e de intervenção terapêutica. Atualização para os clínicos
Forti, N. A., & Diament, J. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001800019 · Cited by 43
Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
Gourgari, E., Playford, M. P., Campia, U., Dey, A. K., Cogen, F. R., Gubb-Weiser, S., Méte, M., Desale, S. Y., Sampson, M. L., Taylor, A. J., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0802-0 · Cited by 41
High-sensitive C-reactive protein level and oxidative stress-related status in former athletes in relation to traditional cardiovascular risk factors
Pihl, E., Zilmer, K., Kullisaar, T., Kairane, Č., Pulges, A., & Zilmer, M. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.015 · Cited by 41
“Also, TG:HDL-C [19] and oxLDL:LDL-C [20] ratios were calculated.”
Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults
Oelrich, B., Dewell, A., & Gardner, C. D. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.06.003 · Cited by 41
“[33] subjects were classified as phenotypes A (large particle size; 26.”
Background
Triacylglycerol and coronary heart disease
Austin, M. A. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970066 · Cited by 41
Self-citation
Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause
Griffin, B. A., FARISH, E., Walsh, D., Barnes, J. F., CASLAKE, M. J., Shepherd, J., & Hart, D. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02394.x · Cited by 41
Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease
Shanker, J., Perumal, G., Rao, V. S., Khadrinarasimhiah, N. B., John, S., Hebbagodi, S., Mukherjee, M. S., & Kakkar, V. V. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-33 · Cited by 40
LDL size: does it matter?
Berneis, K. K., & Rizzo, M. (2004) · Swiss Medical Weekly · doi:10.4414/smw.2004.10813 · Cited by 40

Authors: Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M.
Affiliations: University of California, Berkeley (US)
ORCID: King, M C
Krauss, R M
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 82
Issue: 2
Pages: 495-506
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.82.2.495
OpenAlex: W2089286420
Cited by: 1,411
References: 63
Citations by year: 2026: 11 · 2025: 15 · 2024: 17 · 2023: 39 · 2022: 20 · 2021: 26 · 2020: 25 · 2019: 27 · 2018: 17 · 2017: 21 · 2016: 27 · 2015: 42 · 2014: 38 · 2013: 46 · 2012: 39
FWCI: 47.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy (DE-AC03-?, AC03-76SF00098, DEAC03-76SF00098)
National Institutes of Health (7r29hl038760-03, 5p01hl018574-26, DE-AC03- 76SF00098)
National Heart, Lung, and Blood Institute (HL38760, HL-18574)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: atherogenic lipoprotein phenotype, LDL subclasses, low-density lipoprotein, coronary heart disease risk, genetic markers, single-gene inheritance, apolipoprotein B, apolipoprotein A-I, HDL cholesterol, HDL2, triglycerides, VLDL, intermediate density lipoprotein
MeSH terms: Adolescent, Adult, Aged, Arteriosclerosis, Child, Child, Preschool, Chromosome Mapping, Coronary Disease, Female, Genetic Markers, Humans, Lipids, Lipoproteins, Cholesterol, HDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks